The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer

Diana J. Uribe, Edward K. Mandell, Adam Watson, Jesse D. Martinez, Jonathan A. Leighton, Sourav Ghosh, Carla V. Rothlin

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

The receptor tyrosine kinases (RTKs) TYRO3, AXL and MERTK (TAM) have well-described oncogenic functions in a number of cancers. Notwithstanding, TAM RTKs are also potent and indispensable inhibitors of inflammation. The combined deletion of Axl and Mertk in mice enhances chronic inflammation and autoimmunity, including increased inflammation in the gut and colitis-associated cancer. On the other hand, deletion of Tyro3 increases the risk of allergic responses. Therefore, the indiscriminate inhibition of these TAM RTKs could result in undesirable immunological diseases. Here we show that AXL, but not MERTK or TYRO3 expression is enhanced in late stage colorectal cancer (CRC) and AXL expression associates with a cell migration gene signature. Silencing AXL or the inhibition of AXL kinase activity significantly inhibits tumor cell migration and invasion. These results indicate that the selective inhibition of AXL alone might confer sufficient therapeutic benefit in CRC, while preserving at least some of the beneficial, anti-inflammatory effects of MERTK and TYRO3 RTKs.

Original languageEnglish (US)
Article numbere0179979
JournalPloS one
Volume12
Issue number7
DOIs
StatePublished - Jul 2017

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer'. Together they form a unique fingerprint.

Cite this